In September 2025, a sweeping recall of atorvastatin—the nation's most-prescribed cholesterol-lowering drug—sent shockwaves through the American healthcare system. The U.S. Food and Drug ...

On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the federal agency indicates that the recalled medications could cause "temporary ...

More than 140,000 bottles of a popular prescription medication used to treat high cholesterol have been recalled because of a flaw that may limit the effectiveness of the drug. Ascend Laboratories, ...

More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that could make the medication less effective.

lower cholesterol levels in adults and some children reduce the risk of heart and blood vessel problems caused by high cholesterol, such as heart attack and stroke, in adults reduce the need for ...

Atorvastatin, one of the world’s most widely prescribed cholesterol-lowering drugs, has played a major role in reducing heart ...

Late last week, District Court Judge Peter Sheridan (D.N.J.) dismissed with prejudice the complaint for antitrust injury by the so-called "End Payor Class Purchasers" against the parties in previous ...